|
May 7
|
Evotec SE (EVO) Q1 2025 Earnings Call Highlights: Navigating Revenue Challenges and Embracing ...
|
|
May 7
|
Evotec Receives $ 2.5 m Grant to Generate Next Generation Tuberculosis Treatments
|
|
May 6
|
Evotec SE Reports Q1 2025 results: Paving the Way for 2025 Growth in Soft Market Environment
|
|
Apr 24
|
Evotec Announces Significant Progress in Strategic Protein Degradation Collaboration with Bristol Myers Squibb
|
|
Apr 18
|
Evotec SE (EVO) (Q4 2024) Earnings Call Highlights: Strong Q4 Performance and Strategic ...
|
|
Apr 17
|
Evotec SE Unveils New Strategy and Provides 2025 Guidance Bolstered by Strong Q4 2024 Results
|
|
Apr 10
|
Evotec SE to Announce Results for Financial Year 2024 on 17 April 2025
|